Common Contracts

Contract

February 5th, 2019

• Filed
  February 5th, 2019

Sponsored Clinical Trial Agreement Zmluva o sponzorovanom klinickom skúšaní A Phase 3 Randomized, Double-blind, Placebo- controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects with Moderate to Severe Ulcerative Colitis (FIGARO UC 302) Randomizované, dvojito zaslepené, placebom kontrolované klinické skúšanie fázy 3 prebiehajúce v paralelných skupinách, na sledovanie účinnostia bezpečnosti skúšaného produktu SHP647 ako zahajovacej liečby pacientov so stredne ťažkou ažťažkou formou ulceróznej kolitídy (FIGARO UC 302) Shire Human Genetic Therapies, Inc. Clinical Protocol No. SHP647-302 Shire Human Genetic Therapies, Inc. Klinický protokol č. SHP647-302 THIS SPONSORED CLINICAL TRIALAGREEMENT (the “Agreement”) is made as of the day following the date of its publication in the Central Register of Contracts (the “Effective Date”), by and among TÚTO ZMLUVU O SPONZOROVANOMKLINICKOM SKÚŠANÍ (ďalej len „zmluva“) uzatvárajú zmluvu účinnú v deň nasled